{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:58:17Z","timestamp":1784757497749,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007489","name":"Bausch & Lomb","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007489","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40123-018-0141-y","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T08:20:25Z","timestamp":1533802825000},"page":"417-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antibiotic Resistance Rates by Geographic Region Among Ocular Pathogens Collected During the ARMOR Surveillance Study"],"prefix":"10.1007","volume":"7","author":[{"given":"Penny A.","family":"Asbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul T.","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"issue":"3","key":"141_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4103\/0255-0857.83903","volume":"29","author":"S Sharma","year":"2011","unstructured":"Sharma S. Antibiotic resistance in ocular bacterial pathogens. Indian J Med Microbiol. 2011;29(3):218\u201322.","journal-title":"Indian J Med Microbiol."},{"issue":"1","key":"141_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12886-017-0612-2","volume":"17","author":"M Teweldemedhin","year":"2017","unstructured":"Teweldemedhin M, Gebreyesus H, Atsbaha AH, et al. Bacterial profile of ocular infections: a systematic review. BMC Ophthalmol. 2017;17(1):212.","journal-title":"BMC Ophthalmol."},{"key":"141_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4137\/OED.S4866","volume":"3","author":"D Bremond-Gignac","year":"2011","unstructured":"Bremond-Gignac D, Chiambaretta F, Milazzo S. A European perspective on topical ophthalmic antibiotics: current and evolving options. Ophthalmol Eye Dis. 2011;3:29\u201343.","journal-title":"Ophthalmol Eye Dis."},{"key":"141_CR4","first-page":"813979","volume":"2015","author":"N Wang","year":"2015","unstructured":"Wang N, Yang Q, Tan Y, et al. Bacterial spectrum and antibiotic resistance patterns of ocular infection: differences between external and intraocular diseases. J Ophthalmol. 2015;2015:813979.","journal-title":"J Ophthalmol."},{"key":"141_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/OPTH.S5778","volume":"3","author":"JS Bertino Jr","year":"2009","unstructured":"Bertino JS Jr. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol. 2009;3:507\u201321.","journal-title":"Clin Ophthalmol."},{"issue":"6","key":"141_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1590\/S0004-27492013000600006","volume":"76","author":"ME Vola","year":"2013","unstructured":"Vola ME, Moriyama AS, Lisboa R, et al. Prevalence and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in ocular infections. Arq Bras Oftalmol. 2013;76(6):350\u20133.","journal-title":"Arq Bras Oftalmol."},{"issue":"4","key":"141_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","volume":"10","author":"M Frieri","year":"2017","unstructured":"Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369\u201378.","journal-title":"J Infect Public Health."},{"issue":"3","key":"141_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.mayocp.2012.01.007","volume":"87","author":"SG Jenkins","year":"2012","unstructured":"Jenkins SG, Schuetz AN. Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clin Proc. 2012;87(3):290\u2013308.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"141_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.17925\/USOR.2017.10.01.35","volume":"10","author":"PA Asbell","year":"2017","unstructured":"Asbell PA, Sanfilippo CM. Antibiotic resistance trends among ocular pathogens in the US\u2014cumulative results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study. US Ophthalmic Rev. 2017;10(1):35\u20138.","journal-title":"US Ophthalmic Rev."},{"issue":"3","key":"141_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/ICO.0000000000000352","volume":"34","author":"N Ni","year":"2015","unstructured":"Ni N, Nam EM, Hammersmith KM, et al. Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern pennsylvania. Cornea. 2015;34(3):296\u2013302.","journal-title":"Cornea"},{"issue":"11","key":"141_CR11","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3201\/eid1411.080337","volume":"14","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH. Growth and geographic variation in hospitalizations with resistant infections, united states, 2000-2005. Emerg Infect Dis. 2008;14(11):1756\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"141_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1586\/eop.13.7","volume":"8","author":"RP Kowalski","year":"2013","unstructured":"Kowalski RP. Is antibiotic resistance a problem in the treatment of ophthalmic infections? Expert Rev Ophthalmol. 2013;8(2):119\u201326.","journal-title":"Expert Rev Ophthalmol."},{"issue":"4","key":"141_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","volume":"152","author":"W Haas","year":"2011","unstructured":"Haas W, Pillar CM, Torres M, et al. Monitoring antibiotic resistance in ocular microorganisms: Results from the antibiotic resistance monitoring in ocular microrganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol. 2011;152(4):567\u2013574e3.","journal-title":"Am J Ophthalmol."},{"issue":"12","key":"141_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/jamaophthalmol.2015.3888","volume":"133","author":"PA Asbell","year":"2015","unstructured":"Asbell PA, Sanfilippo CM, Pillar CM, et al. Antibiotic resistance among ocular pathogens in the united states: five-year results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study. JAMA Ophthalmol. 2015;133(12):1445\u201354.","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"141_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1128\/AAC.01915-13","volume":"58","author":"SS Richter","year":"2014","unstructured":"Richter SS, Diekema DJ, Heilmann KP, et al. Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States. Antimicrob Agents Chemother. 2014;58(2):740\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"141_CR16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/meajo.MEAJO_276_16","volume":"24","author":"D Miller","year":"2017","unstructured":"Miller D. Update on the epidemiology and antibiotic resistance of ocular infections. Middle East Afr J Ophthalmol. 2017;24(1):30\u201342.","journal-title":"Middle East Afr J Ophthalmol."},{"issue":"5","key":"141_CR17","doi-asserted-by":"publisher","first-page":"e0178254","DOI":"10.1371\/journal.pone.0178254","volume":"12","author":"N Blanco","year":"2017","unstructured":"Blanco N, Perencevich E, Li SS, et al. Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US. PLoS One. 2017;12(5):e0178254.","journal-title":"PLoS One"},{"key":"141_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13756-017-0185-0","volume":"6","author":"M Oydanich","year":"2017","unstructured":"Oydanich M, Dingle TC, Hamula CL, et al. Retrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at mount sinai hospital, 2010 to 2015. Antimicrob Resist Infect Control. 2017;6:29.","journal-title":"Antimicrob Resist Infect Control."},{"issue":"3","key":"141_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/jop.2012.0081","volume":"29","author":"D Miller","year":"2013","unstructured":"Miller D, Chang JS, Flynn HW, et al. Comparative in vitro susceptibility of besifloxacin and seven comparators against ciprofloxacin- and methicillin-susceptible\/nonsusceptible staphylococci. J Ocul Pharmacol Ther. 2013;29(3):339\u201344.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"141_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.diagmicrobio.2014.12.009","volume":"81","author":"RK Flamm","year":"2015","unstructured":"Flamm RK, Mendes RE, Hogan PA, et al. In vitro activity of linezolid as assessed through the 2013 leader surveillance program. Diagn Microbiol Infect Dis. 2015;81(4):283\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"141_CR21","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1128\/AAC.04614-14","volume":"59","author":"HS Sader","year":"2015","unstructured":"Sader HS, Flamm RK, Streit JM, et al. Ceftaroline activity against bacterial pathogens frequently isolated in US Medical centers: results from five years of the AWARE surveillance program. Antimicrob Agents Chemother. 2015;59(4):2458\u201361.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"141_CR22","doi-asserted-by":"publisher","first-page":"e01043-17","DOI":"10.1128\/AAC.01043-17","volume":"61","author":"HS Sader","year":"2017","unstructured":"Sader HS, Mendes RE, Streit JM, et al. Antimicrobial susceptibility trends among Staphylococcus aureus isolates from US Hospitals: Results from 7 years of the ceftaroline (AWARE) surveillance program, 2010 to 2016. Antimicrob Agents Chemother. 2017;61(9):e01043-17.","journal-title":"Antimicrob Agents Chemother."},{"key":"141_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2147\/OPTH.S9604","volume":"4","author":"TL Comstock","year":"2010","unstructured":"Comstock TL, Karpecki PM, Morris TW, et al. Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis. Clin Ophthalmol. 2010;4:215\u201325.","journal-title":"Clin Ophthalmol."},{"issue":"3","key":"141_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jac\/dkn528","volume":"63","author":"E Cambau","year":"2009","unstructured":"Cambau E, Matrat S, Pan XS, et al. Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother. 2009;63(3):443\u201350.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"141_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000330858","volume":"57","author":"CM Sanfilippo","year":"2011","unstructured":"Sanfilippo CM, Hesje CK, Haas W, et al. Topoisomerase mutations that are associated with high-level resistance to earlier fluoroquinolones in Staphylococcus aureus have less effect on the antibacterial activity of besifloxacin. Chemotherapy. 2011;57(5):363\u201371.","journal-title":"Chemotherapy"},{"issue":"1","key":"141_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40123-016-0046-6","volume":"5","author":"FS Mah","year":"2016","unstructured":"Mah FS, Sanfilippo CM. Besifloxacin: efficacy and safety in treatment and prevention of ocular bacterial infections. Ophthalmol Ther. 2016;5(1):1\u201320.","journal-title":"Ophthalmol Ther."},{"issue":"2","key":"141_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.femsim.2004.05.004","volume":"42","author":"MR Sannes","year":"2004","unstructured":"Sannes MR, Kuskowski MA, Johnson JR. Geographical distribution of antimicrobial resistance among Escherichia coli causing acute uncomplicated pyelonephritis in the united states. FEMS Immunol Med Microbiol. 2004;42(2):213\u20138.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"141_CR28","doi-asserted-by":"publisher","first-page":"e20153099","DOI":"10.1542\/peds.2015-3099","volume":"137","author":"DE Sutter","year":"2016","unstructured":"Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016;137(4):e20153099.","journal-title":"Pediatrics."},{"issue":"4","key":"141_CR29","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther. 2015;40(4):277\u201383.","journal-title":"Pharm Ther"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-018-0141-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-018-0141-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-018-0141-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:50:30Z","timestamp":1724413830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-018-0141-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["141"],"URL":"https:\/\/doi.org\/10.1007\/s40123-018-0141-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}